Your browser doesn't support javascript.
loading
Anti-IFN-γ autoantibodies underlie disseminated Talaromyces marneffei infections.
Guo, Jing; Ning, Xin-Qiang; Ding, Jing-Ya; Zheng, Yan-Qing; Shi, Na-Na; Wu, Feng-Yao; Lin, You-Kun; Shih, Han-Po; Ting, He-Ting; Liang, Gang; Lu, Xiang-Chan; Kong, Jin-Ling; Wang, Ke; Lu, Yi-Bo; Fu, Yu-Jiao; Hu, Rong; Li, Tian-Min; Pan, Kai-Su; Li, Xiu-Ying; Huang, Chun-Yang; Lo, Yu-Fang; Chang, Ian Yi-Feng; Yeh, Chun-Fu; Tu, Kun-Hua; Tsai, Yu-Huan; Ku, Cheng-Lung; Cao, Cun-Wei.
  • Guo J; Department of Dermatology and Venereology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Ning XQ; Department of Dermatology and Venereology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Ding JY; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, Guangxi, China.
  • Zheng YQ; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Shi NN; Department of Dermatology and Venereology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Wu FY; Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
  • Lin YK; Department of Dermatology and Venereology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Shih HP; Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
  • Ting HT; Department of Dermatology and Venereology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Liang G; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Lu XC; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Kong JL; School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi, China.
  • Wang K; Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
  • Lu YB; Department of Respiratory Medicine, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Fu YJ; School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi, China.
  • Hu R; Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
  • Li TM; Department of Dermatology and Venereology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Pan KS; Department of Dermatology and Venereology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Li XY; Department of Dermatology and Venereology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Huang CY; Department of Dermatology and Venereology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Lo YF; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, Guangxi, China.
  • Chang IY; Department of Dermatology and Venereology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Yeh CF; Department of Dermatology and Venereology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Tu KH; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, Guangxi, China.
  • Tsai YH; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Ku CL; Core Laboratory, Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.
  • Cao CW; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
J Exp Med ; 217(12)2020 12 07.
Article en En | MEDLINE | ID: mdl-32880631

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Autoanticuerpos / Interferón gamma / Talaromyces / Micosis Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Autoanticuerpos / Interferón gamma / Talaromyces / Micosis Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article